Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$7.84 - $23.29 $75,585 - $224,538
-9,641 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$5.57 - $11.5 $146,557 - $302,588
-26,312 Reduced 73.18%
9,641 $81,000
Q4 2019

Feb 14, 2020

BUY
$7.9 - $10.14 $284,028 - $364,563
35,953 New
35,953 $351,000
Q3 2019

Nov 14, 2019

SELL
$9.17 - $12.01 $429,421 - $562,416
-46,829 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$10.88 - $17.6 $509,499 - $824,190
46,829 New
46,829 $556,000
Q3 2018

Nov 13, 2018

SELL
$14.85 - $16.35 $151,187 - $166,459
-10,181 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$13.8 - $16.8 $140,497 - $171,040
10,181 New
10,181 $162,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.